This situation is strongly reminiscent of FSHD patient biopsies, where histological signs are obvious, the DUX4 target gene expression profile is detectable, but the DUX4 protein has proven very difficult to identify by immunohistochemistry. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.